SCOPUS 정보 검색 플랫폼

Journal of Oncology Pharmacy Practice

Volumn 17, Issue 3, 2011, Pages 282-284

Complete heart block secondary to bortezomib use in multiple myeloma

(1) Dasanu, Constantin A a

a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER (United States)

Author keywords

arrhythmia; autonomic nervous system; bortezomib; cardiac rhythm; complete heart block

Indexed keywords

ACICLOVIR; ALENDRONIC ACID; AMLODIPINE; BORTEZOMIB; DEXAMETHASONE; GEMFIBROZIL; LISINOPRIL;

AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; AUTONOMIC NERVOUS SYSTEM; BRADYCARDIA; CASE REPORT; COMPLETE HEART BLOCK; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; DIZZINESS; ELECTROCARDIOGRAM; FEMALE; HEART RHYTHM; HEART SOUND; HERPES ZOSTER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MEDICAL LITERATURE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; OSTEOARTHRITIS; OSTEOPOROSIS; PACEMAKER; PRIORITY JOURNAL; SENSORY NEUROPATHY; WEAKNESS;

AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; AUTONOMIC NERVOUS SYSTEM; BORONIC ACIDS; CARDIAC PACING, ARTIFICIAL; ELECTROCARDIOGRAPHY; FEMALE; HEART BLOCK; HUMANS; MULTIPLE MYELOMA; PACEMAKER, ARTIFICIAL; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; TREATMENT OUTCOME;

EID: 80053307371 PISSN: 10781552 EISSN: 1477092X Source Type: Journal
DOI: 10.1177/1078155210367839 Document Type: Article

Times cited : (21)

References (7)

1
- 33847293709
- Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat
- DOI 10.1016/j.expneurol.2006.11.010, PII S0014488606006170
- Cavaletti G., Gilardini A., Canta A., Rigamonti L., Rodriguez-Menendez V., Ceresa C., et al. Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat. Exp Neurol 2007 ; 204: 317-325. (Pubitemid 46330280)
- (2007) Experimental Neurology , vol.204 , Issue.1 , pp. 317-325
- Cavaletti, G.¹ Gilardini, A.² Canta, A.³ Rigamonti, L.⁴ Rodriguez-Menendez, V.⁵ Ceresa, C.⁶ Marmiroli, P.⁷ Bossi, M.⁸ Oggioni, N.⁹ D'Incalci, M.¹⁰ De Coster, R.¹¹

2
- 33746010219
- Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib
- DOI 10.1200/JCO.2005.04.7779
- Richardson PG, Briemberg H., Jagannath S., Wen PY, Barlogie B., Berenson J., et al. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib. J Clin Oncol 2006 ; 24: 3113-3120. (Pubitemid 46638949)
- (2006) Journal of Clinical Oncology , vol.24 , Issue.19 , pp. 3113-3120
- Richardson, P.G.¹ Briemberg, H.² Jagannath, S.³ Wen, P.Y.⁴ Barlogie, B.⁵ Berenson, J.⁶ Singhal, S.⁷ Siegel, D.S.⁸ Irwin, D.⁹ Schuster, M.¹⁰ Srkalovic, G.¹¹ Alexanian, R.¹² Rajkumar, S.V.¹³ Limentani, S.¹⁴ Alsina, M.¹⁵ Orlowski, R.Z.¹⁶ Najarian, K.¹⁷ Esseltine, D.¹⁸ Anderson, K.C.¹⁹ Amato, A.A.²⁰ more..

3
- 70349575412
- Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: Results of a phase 1 dose-escalation study
- Reece DE, Sanchorawala V., Hegenbart U., Merlini G., Palladini G., Fermand JP, et al. Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study. Blood 2009 ; 114: 1489-1497.
- (2009) Blood , vol.114 , pp. 1489-1497
- Reece, D.E.¹ Sanchorawala, V.² Hegenbart, U.³ Merlini, G.⁴ Palladini, G.⁵ Fermand, J.P.⁶

4
- 56649108096
- Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib
- Hacihanefioglu A., Tarkun P., and Gonullu E. Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib. Int J Hematol 2008 ; 88: 219-222.
- (2008) Int J Hematol , vol.88 , pp. 219-222
- Hacihanefioglu, A.¹ Tarkun, P.² Gonullu, E.³

5
- 4644248931
- Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors
- DOI 10.1158/1078-0432.CCR-04-0422
- Shah MH, Young D., Kindler HL, Webb I., Kleiber B., Wright J., et al. Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors. Clin Cancer Res 2004 ; 10: 6111-6118. (Pubitemid 39287516)
- (2004) Clinical Cancer Research , vol.10 , Issue.18 , pp. 6111-6118
- Shah, M.H.¹ Young, D.² Kindler, H.L.³ Webb, I.⁴ Kleiber, B.⁵ Wright, J.⁶ Grever, M.⁷

6
- 69149099171
- Multiple significant bortezomib-related toxicities in one patient: Case report and literature review
- Waller JM, Moretto JC, and Knopf KB Multiple significant bortezomib-related toxicities in one patient: case report and literature review. Clin Lymphoma Myeloma 2009 ; 9: E1 - E4.
- (2009) Clin Lymphoma Myeloma , vol.9
- Waller, J.M.¹ Moretto, J.C.² Knopf, K.B.³

7
- 27644510071
- Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma
- DOI 10.1002/cncr.21427
- Berenson JR, Jagannath S., Barlogie B., Siegel DT, Alexanian R., Richardson PG, et al. Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma. Cancer 2005 ; 104: 2141-2148. (Pubitemid 41579960)
- (2005) Cancer , vol.104 , Issue.10 , pp. 2141-2148
- Berenson, J.B.¹ Jagannath, S.² Barlogie, B.³ Siegel, D.T.⁴ Alexanian, R.⁵ Richardson, P.G.⁶ Irwin, D.⁷ Alsina, M.⁸ Rajkumar, S.V.⁹ Srkalovic, G.¹⁰ Singhal, S.¹¹ Limenitani, S.¹² Niesvizky, R.¹³ Esseltine, D.L.¹⁴ Trehu, E.¹⁵ Schenkein, D.P.¹⁶ Anderson, K.¹⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.